Physician profile
Daniel Landis
NPI 1013930643
$1,161.08
in general payments reported to CMS, 2019-2025
6 companies · $253 in 2025
The $253 reported for 2025 was more than what a typical Radiation Oncology provider received nationally (typical 2025 total: $172).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $440 · 2023: $444 · 2024: $23.72 · 2025: $253.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $721.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $721.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $440.00 | 2022 | |
| Astrazeneca Pharmaceuticals LP | $337.68 | 2023-2025 | Datroway, Enhertu, Calquence |
| Myriad Genetic Laboratories, INC. | $194.06 | 2023-2024 | Prolaris |
| Sumitomo Pharma America, INC. | $107.70 | 2025 | Orgovyx |
| Accuray Incorporated | $61.29 | 2023 | Cyberknife System |
| Abbott Laboratories | $20.35 | 2025 | Cardiomems |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniel Landis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.